期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Effects of neuroprotectant cocktails on focal cerebral ischemia in rats 被引量:4
1
作者 潘殿卿 李志梅 李春岩 《中国临床康复》 CSCD 2003年第5期842-844,T002,共4页
AIM:To investigate whether cocktail theraphy combined with of neuroprotectants may have more advantages over single agents in treating focal cerebral ischemic cascade.METHODS:With the use of suture occlusin techique,t... AIM:To investigate whether cocktail theraphy combined with of neuroprotectants may have more advantages over single agents in treating focal cerebral ischemic cascade.METHODS:With the use of suture occlusin techique,the right middle cerebral artery in rats was occluded.Tirty minutes later,Frutose 1,6 diphosphate(FDP) (50 mg/kg,n=20), MK 801(1 mg/kg,n=20) and N acetylcystein (NAC)(150 mg/kg,n=20) were singly or combinantly infused intraperitoneally.At the same time the cocktail treated group(n=20)were infused the above agents combinationly and the control group(n=20)were infused normal saline intraperitoneally.6 hours and 24 hours after focal cerebral ischemia the animals were weighted and neurologically assessed on 5 point scale.The animals were killed,brains were stained 2,3,5 triphenyltetrazolium chloride for assessment of the infarct volume and then embedden onto slides with paraffin for morphological assessment and terminal transferase dUTP nick ending labeling(TUNEL )were carried out for apoptosis and immunohistochemistry were carried out to investigate the changes in bcl 2.RESULTS:All Neuroprotectants decreased volume of infarction (P< 0.05,F test).While cocktail treated group showed more distinct decrease than other groups(P< 0.05,F test).FDP treated group did not decrease the apoptosis of the neurons and did not increase the bcl 2 expression as well.MK 801 treated group,NAC treated group and cocktail treated group significantly decreased the apoptosis of the neurons and increased the bcl 2 expression (P< 0.05,F test).With cocktail treated group showing more distinct effect (P< 0.05,F test).CONCLUSION:Cocktail may be more effective than single neuroprotectant in this modle. 展开更多
关键词 神经保护剂 鸡尾酒疗法 大鼠 局灶性脑缺血
下载PDF
脑卒中治疗靶点和药物研究 被引量:21
2
作者 缪朝玉 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2016年第12期1264-1272,共9页
脑卒中作为我国人口第一大致死原因,已成为严重影响国计民生的公共卫生问题,但仅3%~5%患者可接受唯一获准的缺血性脑卒中药物组织型纤溶酶原激活剂治疗,出血性脑卒中更是无药可用。因此,脑卒中药物治疗迫切需要解决。尽管目前已认识到... 脑卒中作为我国人口第一大致死原因,已成为严重影响国计民生的公共卫生问题,但仅3%~5%患者可接受唯一获准的缺血性脑卒中药物组织型纤溶酶原激活剂治疗,出血性脑卒中更是无药可用。因此,脑卒中药物治疗迫切需要解决。尽管目前已认识到神经保护剂可作为缺血性脑卒中和出血性脑卒中治疗的共性策略,但大量神经保护剂在临床试验中的转化失败,使得脑卒中药物研究成为世界性难题。本文将结合当前脑卒中治疗策略和药物研发现状,阐述靶向兴奋毒性、氧化和硝化应激、炎症反应的脑卒中损伤机制及相应药物的临床试验进展,并从新的视角提出增强机体内在防御机制作为脑卒中治疗的新策略,重点阐述本课题组研究的烟酰胺磷酸核糖转移酶(Nampt)-烟酰胺腺嘌呤二核苷酸防御系统及其抗脑卒中新靶点Nampt,以及在研新药烟酰胺单核苷酸。希望通过不懈努力,能够破解脑卒中治疗的瓶颈问题,减轻社会和家庭的经济负担和精神压力,造福于人类。 展开更多
关键词 脑卒中 治疗靶点 药物研究 神经保护剂 烟酰胺磷酸核糖转移酶 分泌蛋白
下载PDF
醒窍化痰汤加减结合脑神经保护剂对急性脑梗死患者NIHSS评分的影响及疗效观察 被引量:1
3
作者 俞郦 《中国社区医师》 2018年第36期105-105,107,共2页
目的:探讨醒窍化痰汤加减结合脑神经保护剂对急性脑梗死患者NIHSS评分的影响及疗效。方法:收治急性脑梗死患者106例,将患者平分为参照组(给予脑神经保护剂治疗)以及观察组(醒窍化痰汤加减结合脑神经保护剂治疗),对比两组治疗前后NIHSS... 目的:探讨醒窍化痰汤加减结合脑神经保护剂对急性脑梗死患者NIHSS评分的影响及疗效。方法:收治急性脑梗死患者106例,将患者平分为参照组(给予脑神经保护剂治疗)以及观察组(醒窍化痰汤加减结合脑神经保护剂治疗),对比两组治疗前后NIHSS评分以及治疗效果。结果:治疗后,两组患者的NIHSS评分均有降低,观察组降低较明显,观察组治疗效果(96.22%)显著优于参照组(84.91%),组间差异有统计学意义(P<0.05)。结论:急性脑梗死的患者在脑神经保护剂的基础上联合醒窍化痰汤加减进行治疗能够有效改善患者NIHSS评分,治疗效果显著。 展开更多
关键词 醒窍化痰汤 脑神经保护剂 急性脑梗死 NIHSS 评分 治疗效果
下载PDF
Anti-aging Related Activities and Health Benefits of Licochalcone A:A Review
4
作者 Iffat Ara Rita Turcio +2 位作者 Tasmia Islam Md.Sabbir Hossain Md.Kamrul Hasan 《Clinical Complementary Medicine and Pharmacology》 2024年第1期85-94,共10页
Background:Licochalcone A(LCA)is a flavonoid derived from the roots of Glycyrrhiza uralensis Fisch.ex DC and other related plants.Its natural source has been extensively used in complementary medicine,especially tradi... Background:Licochalcone A(LCA)is a flavonoid derived from the roots of Glycyrrhiza uralensis Fisch.ex DC and other related plants.Its natural source has been extensively used in complementary medicine,especially traditional Chinese medicine,to treat various ailments.Identified as a phenolic chalcone compound,LCA has gained significant attention in recent years due to its various pharmacological properties.Objective:The objective of this review article is to assess the anti-aging ralated pharmacological properties of LCA.Method:An exhaustive search of several scientific databases was conducted using various relevant keywords to write this review article on LCA,focusing on its therapeutic applications and anti-aging-related pharmacological activities.Some inclusion and exclusion criteria were strictly followed to retrieve updated relevant articles.Results:A collection of 292 papers were screened,and 131 were included in this review for an in-depth analysis of Licochalcone A,focusing on its anti-aging-related pharmacological activities and relevant mechanisms,and its toxicity and side effects.Moreover,the potential of LCA as a pharmacological product is discussed,emphasizing its health benefits and potential as a pharmaceutical product.Conclusion:These findings indicate that Licochalcone A is a promising natural therapeutic agent for anti-aging therapy and other ailments. 展开更多
关键词 Licochalcone A Glycyrrhiza uralensis Chalcone Anti-aging neuroprotective ANTIOXIDANT Skin protection therapeutic agent
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部